TECHNOLOGY

02 — PLATFORM

Two source platforms.
One engineering system.

Mykito combines controlled non-animal production with material engineering to create traceable chitosan that performs consistently from R&D through industrial scale.

Scientist pipetting samples in a biotechnology laboratory
PRECISION BIOLOGY · CONTROLLED MATERIAL ENGINEERING

SOURCE PLATFORMS

02.1

Control begins
at the source.

BioFoundry and ChitoGene create two complementary routes to non-animal chitosan, allowing supply and performance to align with the application.

ENGINEERING PLATFORM

02.2

A specification,
not a commodity.

Mykito engineers the attributes and delivery form that determine how chitosan behaves in the customer’s product.

01

Molecular Engineering

MW and DDA shaped around performance.

Molecular weight and degree of deacetylation influence charge density, solubility, viscosity and biological interactions. Mykito customizes these attributes for the intended application.

  • Custom MW
  • Custom DDA
  • Functional tuning
02

Low Molecular Weight

Sub-20 kDa precision for bioactivity.

A narrow, consistent molecular-weight distribution improves aqueous compatibility and extends chitosan performance beyond conventional acidic systems.

  • Enhanced solubility
  • Narrow distribution
  • Batch consistency
03

EndoFree

Ultra-low endotoxin for sensitive uses.

A high-purity platform engineered for endotoxin levels below 1 EU/g, with controlled MW, DDA and functional performance from research through industrial scale.

  • <1 EU/g
  • High purity
  • Scalable production
04

ABC Bioabsorbability

Absorbable, biocompatible material design.

ABC supports absorbable medical-material development with tunable degradation and versatile forms including fibers, hydrogels, films, coatings and sponges.

  • Biocompatible
  • Controlled degradation
  • Versatile forms
05

Custom Formulations

Move from promising polymer to usable product.

Application-specific liquids, blends and delivery systems reduce formulation work and help customers evaluate chitosan in a commercially relevant form.

  • Application-led
  • Evaluation-ready
  • Scale-up focused

QUALITY

02.3

Quality is not a claim.
It is the operating system.

Medical, pharmaceutical, food and industrial customers need more than a pure polymer. They need documented control of the source, the process, the specification and every material input.

ISO

QUALITY + FOOD SAFETY

9001
22000

Quality systems aligned with recognized industry frameworks.

ALIGNED
QMS

GOOD MANUFACTURING PRACTICE

GMP

Documented procedures, controls, review and traceability.

CORE SYSTEM
ISO

MEDICAL DEVICE QUALITY

13485

Implementation in progress for internal medical-focused material.

IN PROGRESS
01

STANDARDS ALIGNMENT

Built around recognized quality frameworks.

Mykito’s quality systems align with ISO 9001 and ISO 22000 principles and the current industry requirements relevant to our materials and markets.

02

GMP QUALITY SYSTEM

Control beyond the baseline.

A GMP-based Quality Management System adds disciplined procedures, documentation, review and change control to how medical-focused chitosan is produced.

03

MEDICAL FOCUS

Quality designed for sensitive applications.

Within the internal medical program, the quality focus is dedicated solely to medical chitosan—keeping material control, biological risk and finished-application requirements at the center of development.

04

TRACEABILITY

Every input has a documented path.

Raw ingredients are traceable through sourcing, receipt, production and release—supporting investigation, reproducibility and customer documentation.

05

BIOMEDICAL QUALITY EXPERTISE

Quality is part of the technology.

Our biomedical quality specialists work alongside material and process teams so quality is designed into the specification rather than added after development.